SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-20-000369
Filing Date
2020-03-23
Accepted
2020-03-23 15:12:59
Documents
3
Period of Report
2020-03-23

Document Format Files

Seq Description Document Type Size
1 FORM 6-K correvio6k.htm 6-K 17480
2 MATERIAL CHANGE REPORT DATED MARCH 20, 2020 ex991.htm EX-99.1 22873
3 ARRANGEMENT AGREEMENT DATED MARACH 15, 2020 ex992.htm EX-99.2 594655
  Complete submission text file 0001279569-20-000369.txt   636226
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 20734752
SIC: 2834 Pharmaceutical Preparations